MEI Retained Earnings from 2010 to 2025

MEIP Stock

USD 2.43 0.03 1.22%

MEI Pharma Retained Earnings yearly trend continues to be relatively stable with very little volatility. Retained Earnings are likely to grow to about -331.9 M this year. Retained Earnings is the cumulative amount of net income that MEI Pharma retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2003-06-30

Previous Quarter

-396.2 M

Current Value

-398.9 M

Quarterly Volatility

125.2 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check MEI Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEI Pharma's main balance sheet or income statement drivers, such as Interest Expense of 310.3 K, Selling General Administrative of 28.1 M or Total Revenue of 78.8 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.49 or PTB Ratio of 0.63. MEI financial statements analysis is a perfect complement when working with MEI Pharma Valuation or Volatility modules.

Check out the analysis of MEI Pharma Correlation against competitors.

To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.

Latest MEI Pharma's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of MEI Pharma over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. MEI Pharma's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEI Pharma's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (388.22 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

MEI Retained Earnings Regression Statistics

	Arithmetic Mean	(232,239,959)
	Geometric Mean	169,721,761
	Coefficient Of Variation	(52.90)
	Mean Deviation	103,632,829
	Median	(214,399,000)
	Standard Deviation	122,866,310
	Sample Variance	15096.1T
	Range	402.8M
	R-Value	(0.95)
	Mean Square Error	1479.3T
	R-Squared	0.91
	Slope	(24,598,685)
	Total Sum of Squares	226442T

MEI Retained Earnings History

	2025	-331.9 M
	2024	-349.4 M
	2023	-388.2 M
	2022	-406 M
	2021	-374.2 M
	2020	-327.8 M
	2019	-277.2 M

Other Fundumenentals of MEI Pharma

Retained Earnings Total Equity

MEI Pharma Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Total Liab	Total Current Assets	Retained Earnings	Short Term Investments	Property Plant Equipment	Net Tangible Assets	Good Will	Capital Surpluse	Intangible Assets	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Net Receivables	Short Term Debt
Total Assets		0.65	0.22	0.71	0.96	1.0	-0.57	0.98	0.21	0.65	0.12	0.66	0.12	0.79	0.3	0.94	0.83	-0.15
Total Stockholder Equity	0.65		-0.2	0.2	0.42	0.68	-0.27	0.63	-0.16	0.96	0.58	0.44	0.58	0.49	0.52	0.55	0.61	-0.24
Net Debt	0.22	-0.2		0.48	0.31	0.2	-0.55	0.34	0.57	-0.19	-0.49	0.51	-0.49	0.18	-0.4	0.12	0.08	0.39
Accounts Payable	0.71	0.2	0.48		0.77	0.68	-0.78	0.69	0.57	0.18	-0.01	0.77	-0.01	0.39	-0.32	0.55	0.37	0.22
Total Liab	0.96	0.42	0.31	0.77		0.95	-0.56	0.93	0.26	0.42	-0.08	0.62	-0.08	0.78	0.2	0.94	0.77	-0.11
Total Current Assets	1.0	0.68	0.2	0.68	0.95		-0.55	0.98	0.18	0.68	0.13	0.65	0.13	0.81	0.34	0.94	0.85	-0.17
Retained Earnings	-0.57	-0.27	-0.55	-0.78	-0.56	-0.55		-0.6	-0.84	-0.26	-0.18	-0.93	-0.18	-0.24	0.47	-0.33	-0.27	-0.61
Short Term Investments	0.98	0.63	0.34	0.69	0.93	0.98	-0.6		0.27	0.65	0.06	0.68	0.06	0.79	0.28	0.9	0.81	-0.12
Property Plant Equipment	0.21	-0.16	0.57	0.57	0.26	0.18	-0.84	0.27		-0.13	0.03	0.7	0.03	-0.03	-0.71	-0.02	-0.05	0.77
Net Tangible Assets	0.65	0.96	-0.19	0.18	0.42	0.68	-0.26	0.65	-0.13		0.61	0.36	0.61	0.48	0.52	0.53	0.59	-0.32
Good Will	0.12	0.58	-0.49	-0.01	-0.08	0.13	-0.18	0.06	0.03	0.61		0.19	1.0	-0.08	-0.03	-0.09	-0.08	0.02
Capital Surpluse	0.66	0.44	0.51	0.77	0.62	0.65	-0.93	0.68	0.7	0.36	0.19		0.19	0.39	-0.33	0.44	0.41	0.56
Intangible Assets	0.12	0.58	-0.49	-0.01	-0.08	0.13	-0.18	0.06	0.03	0.61	1.0	0.19		-0.08	-0.03	-0.09	-0.08	0.02
Current Deferred Revenue	0.79	0.49	0.18	0.39	0.78	0.81	-0.24	0.79	-0.03	0.48	-0.08	0.39	-0.08		0.48	0.84	0.87	-0.32
Net Invested Capital	0.3	0.52	-0.4	-0.32	0.2	0.34	0.47	0.28	-0.71	0.52	-0.03	-0.33	-0.03	0.48		0.52	0.65	-0.76
Net Working Capital	0.94	0.55	0.12	0.55	0.94	0.94	-0.33	0.9	-0.02	0.53	-0.09	0.44	-0.09	0.84	0.52		0.9	-0.33
Net Receivables	0.83	0.61	0.08	0.37	0.77	0.85	-0.27	0.81	-0.05	0.59	-0.08	0.41	-0.08	0.87	0.65	0.9		-0.3
Short Term Debt	-0.15	-0.24	0.39	0.22	-0.11	-0.17	-0.61	-0.12	0.77	-0.32	0.02	0.56	0.02	-0.32	-0.76	-0.33	-0.3

Click cells to compare fundamentals

About MEI Pharma Financial Statements

MEI Pharma shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although MEI Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in MEI Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on MEI Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-349.4 M	-331.9 M
Retained Earnings Total Equity	-295 M	-309.8 M

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC